{"id":"https://openalex.org/W2590800680","doi":"https://doi.org/10.1200/jco.2011.29.27_suppl.64","title":"Evaluation of the performance of breast cancer cell line\u2013derived multigene predictors of chemotherapy response in multiple clinical trials.","display_name":"Evaluation of the performance of breast cancer cell line\u2013derived multigene predictors of chemotherapy response in multiple clinical trials.","publication_year":2011,"publication_date":"2011-09-20","ids":{"openalex":"https://openalex.org/W2590800680","doi":"https://doi.org/10.1200/jco.2011.29.27_suppl.64","mag":"2590800680"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.27_suppl.64","doi":"https://doi.org/10.1200/jco.2011.29.27_suppl.64","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.27_suppl.64","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037102607","display_name":"Nan Song","orcid":"https://orcid.org/0000-0002-9182-1060","observed_orcids":["https://orcid.org/0000-0002-9182-1060"]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Song","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090110104","display_name":"Shara D. Rice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. D. Rice","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085880202","display_name":"Dave Gingrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Gingrich","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012416974","display_name":"D. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Wang","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102006079","display_name":"C. Tian","orcid":"https://orcid.org/0009-0003-4148-1795","observed_orcids":["https://orcid.org/0009-0003-4148-1795"]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Tian","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101871035","display_name":"Zhenyu Ding","orcid":"https://orcid.org/0000-0003-1497-5485","observed_orcids":["https://orcid.org/0000-0003-1497-5485"]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Z. Ding","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041136752","display_name":"Stacey L. Brower","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. L. Brower","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045418346","display_name":"Paul R. Ervin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Ervin","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113700548","display_name":"Michael J. Gabrin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. J. Gabrin","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102019539","display_name":"Kui Shen","orcid":"https://orcid.org/0000-0001-6703-7084","observed_orcids":["https://orcid.org/0000-0001-6703-7084"]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Shen","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","Precision Therapeutics, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA; Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]},{"raw_affiliation_string":"Precision Therapeutics, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210098003"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210098003"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"27_suppl","first_page":"64","last_page":"64"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10885","display_name":"Gene expression and cancer classification","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9390000104904175},{"id":"https://openalex.org/keywords/chemotherapy-response-prediction","display_name":"chemotherapy response prediction","score":0.9380000233650208},{"id":"https://openalex.org/keywords/breast-cancer-cell-lines","display_name":"breast cancer cell lines","score":0.9369999766349792},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.7440000176429749},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9959999918937683},{"id":"https://openalex.org/keywords/clinical-validation","display_name":"clinical validation","score":0.5289999842643738},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.7799999713897705},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.871999979019165},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8999999761581421},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.8130000233650208},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.949999988079071}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.8837001323699951},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.781724214553833},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.7563912868499756},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6660323739051819},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6500781774520874},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6047456860542297},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5877816081047058},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5735489130020142},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5297791957855225},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5150299072265625},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.5068483948707581},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5010571479797363},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3925853669643402},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3680635690689087}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.27_suppl.64","doi":"https://doi.org/10.1200/jco.2011.29.27_suppl.64","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.27_suppl.64","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2040998864","https://openalex.org/W7100122816","https://openalex.org/W2026040915","https://openalex.org/W2591293500","https://openalex.org/W2144150278","https://openalex.org/W2048355349","https://openalex.org/W2329260049","https://openalex.org/W2005699380","https://openalex.org/W2162713066","https://openalex.org/W2078562639"],"abstract_inverted_index":{"64":[0],"Background:":[1],"While":[2],"various":[3,79,247],"multi-gene":[4],"predictors":[5,28],"(MGPs)":[6],"of":[7,26,57,60,81,140,180,203,252,261],"chemotherapy":[8,45,166,248,273],"response":[9,46,171],"have":[10],"been":[11],"developed":[12,40],"based":[13],"on":[14],"cancer":[15,20,49,74,111,264,271],"patient":[16,214],"primary":[17],"tissues":[18],"or":[19,152],"cell-lines,":[21],"the":[22,58,157,176,194,201,211,236,250,259],"accuracy":[23],"and":[24,52,97,129,168,191,219,231],"consistency":[25],"these":[27,61,141],"remain":[29],"a":[30,54],"concern":[31],"in":[32,103,119,156,241],"clinical":[33,68,132,142,209,239],"validation":[34],"studies.":[35],"In":[36,138,206,235],"this":[37],"study":[38],"we":[39],"four":[41],"unique":[42],"MGPs":[43,62,181,212,253,267],"for":[44,136],"from":[47,65],"breast":[48,73,110,263,270],"cell":[50],"lines":[51],"performed":[53],"systematic":[55],"evaluation":[56],"performance":[59,202,251],"using":[63,101,186,262],"data":[64],"five":[66,162,207,237],"distinct":[67],"trials.":[69,160],"Methods:":[70],"Forty-six":[71],"immortalized":[72],"cell-lines":[75],"were":[76,122,134,145,154,244],"exposed":[77],"to":[78,199,216,268],"concentrations":[80],"drug":[82],"combinations":[83],"[paclitaxel,":[84],"5-fluorouracil,":[85,89,93],"doxorubicin,":[86,90],"cyclophosphamide":[87,91,95,99],"(TFAC);":[88],"(FAC);":[92],"epirubicin,":[94,98],"(FEC)":[96],"(EC)]":[100],"an":[102,224],"vitro":[104,120],"chemosensitivity":[105,121],"assay.":[106],"Utilizing":[107],"publicly":[108,130],"available":[109,131],"cell-line":[112,265],"microarray":[113],"data,":[114],"genes":[115],"highly":[116],"associated":[117],"with":[118,182,223],"selected":[123],"as":[124,175],"candidate":[125],"MGPs.":[126],"Five":[127],"independent":[128,208,238],"trials":[133,143,240],"used":[135,155,174,198],"validation.":[137],"three":[139,220],"patients":[144,243],"treated":[146,245],"by":[147,246],"TFAC,":[148],"while":[149],"EC,":[150,217],"FAC":[151],"FEC":[153],"other":[158],"two":[159],"All":[161],"studies":[163],"involved":[164],"neoadjuvant":[165],"treatment,":[167],"pathologic":[169],"complete":[170],"(pCR)":[172],"was":[173,184,197],"endpoint.":[177],"The":[178],"association":[179],"pCR":[183,215],"assessed":[185],"receiver-operator":[187],"curve":[188],"(ROC)":[189],"analysis":[190],"area":[192],"under":[193],"ROC":[195],"(AUC)":[196],"evaluate":[200],"prediction.":[204],"Results:":[205],"trials,":[210],"predicted":[213],"FAC/FEC":[218],"TFAC":[221],"treatments":[222],"AUC":[225],"of,":[226],"0.671,":[227],"0.632,":[228],"0.735,":[229],"0.738":[230],"0.647":[232],"respectively.":[233],"Conclusions:":[234],"which":[242],"agents,":[249],"is":[254],"promising.":[255],"These":[256],"results":[257],"demonstrate":[258],"feasibility":[260],"derived":[266],"predict":[269],"patients\u2019":[272],"responses.":[274]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2017-03-03T00:00:00"}